Skeletal growth depends upon enchondral ossification in growth plate cartilage, within which chondrocytes undergo well defined stages of maturation. We infused IGF-I or growth hormone (GH), two key regulators of skeletal growth, into hypophysectomized rats and compared their effects on growth plate chondrocyte differentiation using qualitative and quantitative autoradiography, stereology, and incident light fluorescence microscopy. Stem cell cycle time was shortened from 50 to 15 and 8 d after treatment with IGF-I and GH, respectively. Proliferating cell cycle time decreased from 11 to 4.5 and 3 d, and duration of the hypertrophic phase decreased from 6 to 4 and 2.8 d. Average matrix volume per cell at each differentiation stage was similar for normal, hormone-treated, and untreated hypophysectomized groups. Mean cell volume and cell height were significantly reduced by hypophysectomy at the proliferative and hypertrophic stages, but were restored to physiological values by IGF-I and GH. In contrast, cell productivity, i.e., increases in cell volume, height, and matrix production per unit of time, did not reach normal values with either IGF-I or GH, and this parameter was inversely proportional to cell cycle time or phase duration. IGF-I and GH are thus capable of stimulating growth plate chondrocytes at all stages of differentiation, albeit to variable degrees with respect to individual cell activities. Although it is generally accepted that GH acts […] Research Article
which IGF-I and GH act upon growth plate chondrocytes are largely unknown. Studies addressing this question have used mainly cultured cells or subpopulations of these (5) (6) (7) . Early investigations with cartilage explants from hypophysectomized rats led to the somatomedin hypothesis of Salmon and Daughaday (8, 9) . They postulated that GH did not act directly on sulfate incorporation into cartilage, but that its effects were mediated by a serum factor (somatomedin) produced by the liver ( 10) . Although this proposal was supported by many studies (for review see reference 11 ), others disclosed a direct action ofGH on growth plate chondrocytes ( 12, 13) . This led to a modification of the somatomedin hypothesis. It includes the possibility that GH may act via local production of IGF-I ( 14-16), i.e., by an autocrine/paracrine mechanism. Further data, again derived from in vitro investigations using chondrocyte subpopulations, have indicated that IGF-I influences chondrocytes principally during the proliferative phase by stimulating clonal expansion, whereas GH acts selectively upon stem (resting) cells as a differentiation factor, the ensuing effect on proliferation being triggered by local production of IGF-I (dual effectortheory) (5, 17, 18) .
To date, analysis of IGF-I/GH effects in vivo have been restricted to the measurement of bulk parameters, such as growth plate width, matrix production (35S incorporation), and cell proliferative activity ([3H ]thymidine incorporation)
( 1, 12, 18, 19) . Effects upon individual chondrocyte activities at various stages of differentiation in vivo have not been addressed, and it has therefore not been possible to assess their relative contributions.
It was the aim of this study to elucidate the physiological mechanisms by which IGF-I and GH act upon individual chondrocytes of the growth plate at the various stages ofdifferentiation using the hypophysectomized rat model. The effects of continuously infused IGF-I and GH upon cell proliferative activity, cell height and volume, and net matrix production were investigated for each phase of the chondrocyte life cycle using stereological, autoradiographic, and fluorescence microscopy techniques. Both IGF-I and GH were found to stimulate all phases of chondrocyte differentiation, but IGF-I was less effective than GH.
Methods
To minimize the effects of signaling substances physiologically present in the chondrocyte's natural environment, 35-d-old male Wistar rats were hypophysectomized by a postpyramidal surgical approach (performed by R. Cortesi, Ciba-Geigy AG, Basel, Switzerland). 2 Gentofte, Denmark) were used at doses which in an earlier study had been shown to yield maximal effects with respect to body weight gain and increase in tibial epiphyseal height. When the maximal chosen dose of rhGH was exceeded, growth plate height did not remain stable but decreased, whereas at higher concentrations ofrhIGF-I, the animal mortality rate increased drastically, probably because of hypoglycemia (20) .
Four groups of six animals were investigated: two hypophysectomized and hormone-treated groups; one hypophysectomized group infused with saline served as a control. An age-matched group of normal rats was included for comparative purposes as a standard for physiological chondrocyte activity levels.
Growth rate determination and matrix production. Serum parameters and tissue sampling. Upon termination of each experiment, animals were anesthesized with Innovar Vets (PitmanMoore, Inc., Washington Crossing, NJ; 0.2 ml/ 100 g body wt i.m.) and were bled by aortic puncture. Blood samples were collected on ice and centrifuged for 15 min at 40C (1,500 g), and serum was stored at -20'C. The serum was used for the determination of glucose, IGF-I, testosterone, and free thyroxine levels (see below). Liver, heart, thymus, spleen, and epidydimal fat pads were weighed. The serum levels of IGF-I were measured by radioimmunoassay (21, 22) . Testosterone and free thyroxine levels were determined by standard radioimmunoassay procedures, and glucose levels were determined by a glucose analyzer (model 23A; Yellow Springs Instrument Co., Yellow Springs, OH).
Soft tissues were removed from the left and right tibiae to allow measurement of frontal and sagittal diameters at the level ofthe proximal tibial growth plates (used for the estimation of growth plate reference volume). Then, the growth plates were sawed into sagittal slices, each of which was divided into a number of tissue blocks. These were numbered and, according to a systematic random sampling protocol, three blocks per leg were selected for stereological measurements infusion period (Table II) ; weights of the heart, spleen, liver, kidneys, and thymus increased similarly (data not presented).
More specific indicators of growth include the height of the entire growth plate and of the individual zones, each of which represents a differentiation-specific cell pool (Table II and Fig.  3 ). Proliferating and hypertrophic zone heights were significantly reduced in hypophysectomized control rats, as was total growth plate height (Fig. 3 and Table II ). In IGF-I-treated animals, total growth plate height was similar to that in normal rats, despite dramatically differing growth rate activities (Table  II) . Proliferating cell pool height was greater, and hypertrophic zone height was smaller than in normal animals. GH caused a significantly greater increase in the height of proliferating and hypertrophic zones and of the entire growth plate, but physiological growth rates were not attained. Given that growth rates were clearly highest in normal animals, these data confirm our previous finding (3) that growth plate height, frequently used as a bulk parameter to assess longitudinal growth activity (the so-called "tibia test" of Greenspan et al. [ 19] ), is not a reliable indicator of bone growth rate.
Cell structural characteristics. Mean cell volume and height (Fig. 1 ) are known to ultimately determine the final outcome of longitudinal growth. These structural estimators were reduced in hypophysectomized animals, most notably the mean terminal cell height and volume attained during hypertrophy; mean cell height was also reduced during the proliferative differentiation stage (Figs. 4 and 5) . Mean net matrix volume per cell, lateral cell diameter (data not presented), and the structural estimators describing stem (resting) cells remained unaltered (Fig. 1) .
Surprisingly, both mean cell height and volume were restored to physiological values in the proliferating and hypertro- (IGF-I), 0.025 (GH), and 0.041 (normal rats). Proliferative: 0.026 (NaCI), 0.091 (IGF-I), 0.138 (GH), and 0.248 (normal rats). Hypertrophic: 0.1 (NaCl), 0.3 (IGF-I), 0.4 (GH), and 1.1 (normal rats).
(E) Cell volume increase per hour. Cell volume increase (Am3/h) differed significantly between the various experimental groups. Resting cell: 1 (NaCl), 3.6 (IGF-I), 6 .7 (GH), and 7.0 (normal rats). Proliferative: 4 (NaCI), 15 (IGF-I), 24 (GH), and 42 (normal rats). Hypertrophic: 44 (NaCl), 103 (IGF-I), 166 (GH), and 356 (normal rats). (F) Matrix production per cell and hour. Matrix production per cell and hour (Am3/cell/h) differed significantly between the various experimental groups. Resting cell: 5 (NaCI), 17 (IGF-I), 34 (GH), and 42 (normal rats). Proliferative: 14 (NaCl), 41 (IGF-I), 60 (GH), and 91 (normal rats). Hypertrophic: 49 (NaCl), 86 (IGF-I), 134 (GH), and 262 (normal rats). o, NaCl group (hypophysectomized control); o, IGF-I group; *, GH group; and o, Normal (unhypophysectomized) rat group. phic activity phases after treatment with either IGF-I or GH proliferating and hypertrophic activity phases or between the (Figs. 1, 4 , and 5), whereas mean lateral diameter (data not different experimental groups (data not presented). Hence, no shown) and mean matrix volume per cell (Fig. 1) (12) 1813 (13) 887 (10) 1771 (5) ir. IGF-I (ng/ml) (expressed in human nanogram equivalents)t 24 (18) 412 (13) 202 (9) 403 (5) Mean values for six animals are represented; coefficients of error are given in parentheses. Determinations were made upon termination of experiments. * Chondrocyte hypertrophy required the presence of persisting minimum serum levels of free thyroxine (both in vitro [7, 42, 43] and in vivo [44, 45] ); such a condition pertained in hypophysectomized rats. t Recombinant human IGF-I is 4-5 times more potent than rat IGF-I when determined by radioimmunoassay against rat IGF-I standard. ir., immunoreactive.
groups (Fig. 2 ). These differences were due, above all, to modulations in the cell cycle time (mitotic activity, Fig. 2 A) and, hence, in the kinetics of an axial column (Fig. 2, B and C) . In normal rats, cell columns were found to produce and eliminate 10 cells per day. Hypophysectomy reduced this number to approximately one cell per day, and treatment with IGF-I and GH increased it to three and six cells per day, respectively (Fig.  2 C) . The basis for these effects upon axial (linear) cell production and elimination rates lies in the dramatic influence of signal substances upon cell proliferation and productivity. In the resting (stem) cell phase, the prolonged cycle times induced by hypophysectomy (from 6 [in normal rats] to -50 d) were considerably shortened by IGF-I and GH treatment (to 15 and 8 d, respectively) (Fig. 2 A) . IGF-I thus has a significant stimulatory effect upon stem cell mitosis, and GH almost normalizes this activity. The effects upon cycling activity in the proliferating cell pool were somewhat less dramatic. This parameter decreased from 11 d in hypophysectomized controls (compared with 1.4 d in normal animals) to 4.5 and 3 d after IGF-I and GH treatment, respectively (Fig. 2 A) . The duration of the hypertrophic activity phase was shortened from 6 d in the hypophysectomized control group (compared with 1.2 d in normal rats) to 4.0 and 2.8 d after IGF-I and GH treatment, respectively (Fig. 2 A) . This implies that the time periods needed for elimination of one terminal chondrocyte from cartilage tissue were 16 h in the NaCl group, 8 h in the IGF-I group, 4 h in the GH group, and 2.5 h in normal animals. Given the proportional similarity in chronological effects observed during the chondrocyte differentiation cascade under the various experimental conditions, it is not surprising that the growth fractions (number of proliferating cells divided by the total number of cells per column) did not differ significantly from one another. The absolute cell pool size at each differentiation stage (Fig. 2 B) did vary, however, except in the resting cell phase. The similarity ofthe columnar cell pool size in normal rats and IGF-I-infused animals is surprising in view of the vast difference in growth performance.
Besides cell kinetics, the other main regulatory pathway (4) 27 (11) 31 (4) 36 (5) proliferating zone 97 (2) 146 (3) 174 (2) 128 (3) hypertrophic zone 114 (2) 207 (3) 279 (1) 237 (1) Mean values for six animals are represented; coefficients of error are given in parentheses. * Onset, at the beginning of infusion.
stages; during the stem and proliferating phases, this was in the order of five-to sevenfold, and during hypertrophy three-to fourfold. IGF-l was less effective; it induced an approximately fourfold increase in productivity at the stem and proliferating stages, and a twofold one during hypertrophy.
Discussion Figure 3 . Growth plate structure. Light micrographs of vertical sections through the proximal tibial growth plates of hypophysectomized rats subcutaneously infused with NaCl (A), IGF-I (B), and GH (C); D represents the normal (unhypophysectomized) animals. Down each vertical column, chondrocytes run through a well-defined series ofdifferentiation and activity phases: from the resting (arrowhead), through the proliferative (P), to the hypertrophic (H) cell stage.
Growth plate heights of NaCl, GH, and normal rat groups differed significantly from one another; IGF-I and normal rat group heights were the same. Thick (l -,m) sections stained with toluidine blue 0.
M, zone of mineralization. X 150. Bar = 80 Mum.
subject to significant modulation is cell productivity. The major productivity parameters analyzed were increases in cell height (Fig. 2 D) and cell volume (Fig. 2 E) and net matrix production per unit of time (Fig. 2 F) . In the hypophysectomized control group, these values were reduced by a factor of -10. Treatment with GH stimulated productivity levels at all (3, 4, 24) . In this respect, it is important to note that both IGF-I and GH stimulated structural parameters ofchondrocyte proliferation and hypertrophy maximally relative to normal rats ( Fig.  1) , despite the significantly different growth rates (Table II) . The disparities in growth rate are, therefore, not attributable to modulations in cell structural characteristics, but rather to differences in cell kinetics and cell productivity per unit of time.
The relative increases in growth rate induced by IGF-I and GH are paralleled by proportional increases in cell activity from one differentiation stage to the next, encompassing the stem cell to the terminal hypertrophic phases (Fig. 2) . These findings indicate that both IGF-I and GH exert their influences at each stage of differentiation rather than acting specifically upon particular subpopulations of cells at certain phases of chondrocyte differentiation, as postulated in the "dual effector theory" ( 17, 18, 30) . Although the same final structural parameters were attained with both hormones at the stem cell, proliferative, and hypertrophic phases (Fig. 1) , GH completed structural changes within shorter periods of time (Fig. 2 A) . In all four experimental groups, parameters of cell productivity per unit of time (Fig. 2, D-F) were inversely proportional to cell cycle times (phase duration) (Fig. 2 A) . The quantitative differences between IGF-I and GH action do not argue against the large body of experimental evidence indicating that GH effects on chondrocytes are mediated by IGF-I, although they suggest that this is not an exclusive pathway. These quantitative differences could, at least in part, also be explained by the different modes of action and effectiveness of systemic and locally produced IGF-I. IGF-I infused into hypophysectomized rats circulates mainly in the form of a 40-kD IGF-I-binding protein complex, whereas IGF-I induced by GH infusion is predominantly bound within a 1 50-kD heterotrimeric binding protein complex (22, 31 ) . In contrast to the 40-kD form, the bioavailability of IGF-I in the 1 50-kD form is largely restricted by its limited capillary permeability (32, 33 ditions cannot unequivocally account for quantitative differences in the action of the two hormones. The circulating form of exogenously administered IGF-I would be expected to be more effective than circulating IGF-I induced by GH. On the other hand, GH induces IGF-I locally in growth plate chondrocytes (14) (15) (16) , and locally produced IGF-I, acting immediately as a nascent signaling substance in an auto/ paracrine manner, is probably more effective than the circulating 40-kD form of IGF-I, which has to gain access to target cells via several diffusion barriers. Thus, in contrast to infused exogenous IGF-I, the effects ofGH on chondrocyte differentiation stages are likely to be mediated predominantly by locally produced IGF-I. This is also compatible with the finding that cell-surface receptors for GH, as well as for IGF-I, are present at all stages of differentiation in growth plate cartilage (34) (35) (36) .
A most remarkable aspect of our in vivo study is that IGF-I acts not only at the proliferative phase, but is also capable of influencing chondrocyte differentiation via its effect on stem cells. This finding is supported by analogous data in vitro pertaining to osteoblast (37) and preadipocyte differentiation (38) . Experiments using cultured growth plate chondrocytes have yielded conflicting results in this respect: some studies describe IGF-I acting selectively on the differentiated proliferating cell pool (5), whereas others report that all stages of Figure S growth plate cell differentiation are responsive to this hormone, although to a varying degree (39) (40) (41) . Moreover, contrary to general belief, the effects of IGF-I at the proliferative phase of activity are exerted primarily by a shortening of the cycle time rather than by clonal expansion, i.e., by increasing the cell pool size. All these findings underline that the hitherto applied dual effector theory relating to the mechanisms of action of IGF-I and GH on chondrocytes in vivo requires revision.
